Target intelligence / Profile preview

Voltage-gated sodium channel (inactivated state) (NaV (inactivated state))

Target
NaV (inactivated state)
Molecular classification
Ion channel, Voltage-gated ion channel
01

Overview

Voltage-gated sodium channels (VGSCs) are critical transmembrane proteins responsible for the rapid upstroke of action potentials in excitable tissues such as the brain, heart, and skeletal muscle. These channels transition through distinct functional states: resting (closed), open (conducting), and inactivated (non-conducting). The inactivated state is a refractory period that follows channel opening, mediated by an intracellular loop that plugs the pore to prevent further sodium influx. Pharmacologically, the inactivated state is a major target for state-dependent drugs like local anesthetics, anticonvulsants, and class I antiarrhythmics. These agents bind preferentially to the inactivated conformation, effectively stabilizing it and reducing the availability of channels for subsequent activation. This mechanism allows for the selective inhibition of high-frequency firing or persistently depolarized cells, which is essential for treating pathological conditions like epilepsy, chronic pain, and cardiac arrhythmias while minimizing effects on normal tissue. Understanding the transition between fast and slow inactivation states is also vital for developing next-generation drugs with improved safety profiles.

Other names
Sodium channel inactivated stateNaV channel inactivated stateFast-inactivated stateSlow-inactivated stateVGSC inactivated state
02

Mechanism of action

State-dependent inhibition where drugs bind with higher affinity to the inactivated conformation of the channel, leading to use-dependent block and stabilization of the non-conducting state.

03

Biological functions

Action potential propagationNeuronal excitabilityCardiac rhythm regulationMuscle contractionRefractory period regulation
04

Disease associations

EpilepsyCardiac arrhythmiaChronic painNeuropathic painPeriodic paralysisBrugada syndrome
05

Safety considerations

Pro-arrhythmic effectsCentral nervous system toxicityDizzinessAtaxiaNarrow therapeutic windowCardiac conduction delay
06

Interacting drugs

Lidocaine

8 more in the full profile.

07

Biomarkers

SCN1A gene mutationsSCN5A gene mutationsElectroencephalogram (EEG) spike-wave dischargesElectrocardiogram (ECG) QRS durationQT interval

Beyond the preview

Go deeper on Voltage-gated sodium channel (inactivated state) (NaV (inactivated state)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated sodium channel (inactivated state) (NaV (inactivated state)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call